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Abstract
Background—Folate deficiency, vitamin B-12 deficiency, and anemia can have adverse effects 
on birth outcomes. Also, low vitamin B-12 reduces the formation of metabolically active folate.
Objectives—We sought to establish the baseline prevalence of and factors associated with folate 
deficiency and insufficiency, vitamin B-12 deficiency, and anemia among women of childbearing 
age (WCBA) in Belize.
Methods—In 2011, a national probability-based survey was completed among Belizean 
nonpregnant WCBA aged 15–49 y. Blood samples for determination of hemoglobin, folate (RBC 
and serum), and vitamin B-12 (plasma) and sociodemographic and health information were 
collected from 937 women. RBC and serum folate concentrations were measured by 
microbiologic assay (MBA). Folate status was defined based on both the WHO-recommended 
radioproteinbinding assay and the assay adjusted for the MBA.
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Results—The national prevalence estimates for folate deficiency in WCBA, based on serum and 
RBC folate concentrations by using the assay-matched cutoffs, were 11.0% (95% CI: 8.6%, 
14.0%) and 35.1% (95% CI: 31.3%, 39.2%), respectively. By using the assay-matched compared 
with the WHO-recommended cutoffs, a substantially higher prevalence of folate deficiency was 
observed based on serum (6.9% absolute difference) and RBC folate (28.9% absolute difference) 
concentrations. The prevalence for RBC folate insufficiency was 48.9% (95%CI: 44.8%, 53.1%). 
Prevalence estimates for vitamin B-12 deficiency and marginal deficiency and anemia were 17.2% 
(95% CI: 14.2%, 20.6%), 33.2% (95% CI: 29.6%, 37.1%), and 22.7% (95% CI: 19.5%, 26.2%), 
respectively. The adjusted geometric means of the RBC folate concentration increased 
significantly (P-trend < 0.001) in WCBA who had normal vitamin B-12 status relative to WCBA 
who were vitamin B-12 deficient.
Conclusions—In Belize, the prevalence of folate and vitamin B-12 deficiencies continues to be 
a public health concern among WCBA. Furthermore, low folate status co-occurred with low 
vitamin B-12 status, underlining the importance of providing adequate vitamin B-12 and folic acid 
intake through approaches such as mandatory food fortification.
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Introduction
Folate deficiency, vitamin B-12 deficiency, and anemia can have adverse effects on birth 
outcomes (1, 2). In particular, neural tube defects (NTDs)11 are associated with both 
inadequate folate and vitamin B-12 status of the mother (3–7) and the infant (8–10). 
Inadequate folate status can slow DNA synthesis and cell growth (through the one-carbon 
metabolism pathway), as well as the formation and maturation of RBCs. In addition, 
because vitamin B-12 is necessary for methionine synthase–based activation of folate and 
subsequent entry into one-carbon metabolism, a low concentration of vitamin B-12 can 
contribute to the reduced formation of metabolically active folate, reduced folate retention in 
developing RBCs, and indirect induction of intracellular folate deficiency. Low vitamin B-12 
status is also an independent risk factor for an NTD-affected pregnancy (5, 10–12). 
However, the interaction between folate and vitamin B-12 concentrations has not been 
examined at a population level and may be important for predicting NTD risk and evaluating 
prevention efforts.
Evidence suggests that NTD risk can be reduced if women consume recommended amounts 
of folic acid periconceptionally (5, 13, 14). To prevent folate-sensitive NTDs, the US Public 
Health Service recommended in 1992 that all women capable of becoming pregnant 
consume 400 μg folic acid daily (13). Furthermore, the WHO recently recommended an 
RBC folate concentration of 906 nmol/L (400 ng/L) as the threshold for the optimal 
concentration for NTD risk reduction (15). Many countries have enacted legislative 
11Abbreviations used: BLZ$, Belize dollars; MBA, microbiologic assay; NTD, neural tube defect; PPS, probability proportional to 
size; PRR, prevalence risk ratio; RPBA, radioproteinbinding assay; WCBA, women of childbearing age.
Rosenthal et al. Page 2













regulations and/or micronutrient fortification programs that include folic acid to improve the 
folate status of women of childbearing age (WCBA) (16). However, few fortification 
programs have established monitoring and evaluation to assess the impact of increased folic 
acid intake on the folate status within their populations. The potential impact of folic acid 
fortification programs on NTD prevalence is also largely unknown in most low-to-middle 
income countries because of limited birth-defect surveillance programs (17). Furthermore, 
few countries have included vitamin B-12 in their fortification efforts.
In 2007 Belize established a voluntary wheat flour fortification program as a result of the 
Central American fortification harmonization strategy adopted by the Ministros de Salud de 
Centro America in 2002 (18). The Central American harmonization strategy recommended 
that wheat flour be fortified with the following nutrients (and amounts): thiamin (6.2 mg/
kg), riboflavin (47.2 mg/kg), niacin (55.0 mg/kg), folic acid (1.8 mg/kg), and iron (55.0 mg/
kg). Belize’s voluntary wheat-flour fortification program does not have a monitoring and 
evaluation component to ensure proper fortification concentrations or access to fortified 
wheat flour for the population.
Before establishing a mandatory program, the government wished to establish the baseline 
micronutrient status among nonpregnant WCBA. To address this, the Belizean government 
conducted the Belize National Micronutrient Survey. The objectives of this study were to 
establish the baseline folate status, the vitamin B-12 status, and the prevalence of anemia 
among WCBA and examine the association between folate and vitamin B-12 status by 
sociodemographic characteristics and geographic regions.
Methods
The Belize Institutional Review Board reviewed and approved the study protocol in January 
2011. The study protocol also was reviewed and approved by the CDC Institutional Review 
Board in Atlanta (Georgia). In addition, written consent was obtained from the participating 
women.
Belizean population
In 2010 Belize had a total population of 310,896. Women made up 49.4% of the total 
population, and WCBA made up 27.3% of the total population. At that time, Belize 
consisted of the following diverse ethnic groups: Mestizos (52%), Mayans (11%), Creoles 
and Garifunas (27%), and Mennonites, East Indians, Chinese, and Europeans (10%). An 
estimated 44.5% of the population lived in urban settings, and 55.5% in rural areas (19).
Sampling design
A cross-sectional population survey was conducted among noninstitutionalized WCBA 
(aged 15–49 y) during the period March–June 2011. Because of regional differences in the 
distribution of rural compared with urban populations and indigenous populations in the 
country, a stratified, multistage probability sample was used for each of the 4 regions: 
Central, North, South, and West. Two hundred twenty sectors, 55 in each region, were 
selected by using probability-proportional-to-size (PPS) sampling (20, 21). The first stage of 
the 3-stage sample design was a selection of primary selection units with PPS sampling 
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stratified by urban or rural settings. In the second stage, block groups were selected for each 
sector by using PPS sampling of each secondary sampling unit within each selected primary 
selection unit. All households within the selected block group were listed and updated. In 
the third stage of sampling, households within each selected block group were sampled by 
using a random start point and pre-established systematic selection of adjacent homes. 
Households were visited by trained interviewers to determine their eligibility, defined as 
having ≥1 woman 15–49 y of age residing in the household. The minimum sample size per 
region to estimate a 50%prevalence of folate insufficiency or vitamin B-12 deficiency and 
marginal deficiency with a standard error of ≤7.5%, given a survey design effect of 1.4, was 
266 individuals in each region after adjusting for nonresponse. The final sample provided 
sufficient power to obtain reliable national and regional estimates.
Household interviews
For the households selected in each of the block groups, interviewers used a standardized 
protocol, proceeded door-to-door to explain the study to each household, and identified all 
eligible women residing in the household. When ≥2 eligible women were identified in a 
selected household, one woman was chosen through a random selection process. If a 
selected woman was not available at initial contact, 2 more attempts were made at various 
hours and days. If the woman was never contacted, the household was classified as a 
nonresponse household.
With the use of a standardized questionnaire, interviewers collected sociodemographic 
information, the number of women and children who were household members, primary 
household language, occupation and educational level of the index woman, total family 
income, use of health services, and vitamin use. Pregnancy status was determined by self-
report. Household interviews were conducted in English, Spanish, or Mayan language by 
multilingual interviewers.
Variable definitions
Self-reported data for the following sociodemographic information were obtained from the 
women interviewed: 1) Area was predetermined and defined by the location of the 
household. Urban areas included towns, small cities, and large cities with populations 
≥2500. Rural areas were locations with populations <2500. 2) Ethnicity was self-identified 
(Creole, Garifuna, Mayan, Mestizo, White, and Asian, or Other). Those who self-identified 
as Creole or Garifuna were categorized as Creole/Garifuna, and those who identified as 
White, Asian, or Other were categorized as Other. 3) Age was grouped into 1 of 3 
categories: 15–24, 25–34, and 35–49 y. 4) Education level was based on the highest grade or 
level of education the woman had attained. 5) Monthly family income was grouped into one 
of 4 categories of Belize dollars (BLZ$): ≤699, 700–1399, or >1399 BLZ$, and Don’t Know 
(the respondent did not know the family income). 6) Use of health services was categorized 
as Private, Private and Public, Public, and Other. 7) Intake of a folic acid–containing 
supplement during the last year was categorized as either Yes or No.
After the short interview was completed, blood samples were drawn for measurement and 
assessment of nutritional biomarkers.
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Blood collection and processing
Because of the nature of the survey, blood samples were taken under non-fasting conditions. 
Blood samples were taken by venipuncture into tubes containing EDTA. Whole-blood 
vacutainers were maintained at 4°–8°C for up to several hours before transport to field 
laboratories. At the field laboratories, hemoglobin determination was performed by using 
HemoCue, serum samples were separated and aliquoted, and whole-blood EDTA 
hemolysates were prepared in accordance with CDC laboratory specifications (22). Samples 
were subsequently transported at ≤−20°C to the central Belize Ministry of Health where they 
were stored at ≤−80°C until shipped on dry ice to the University of Florida laboratory in 
Gainesville (Florida).
Biochemical analyses
During the period 2011–2013, the University of Florida laboratory conducted biochemical 
analyses for plasma vitamin B-12 by using the Roche electrochemiluminescence assay on 
the E-170 instrument platform (Roche Vitamin B-12 assay package insert, 2007–8, V4). 
Serum and RBC folate concentrations were determined by microbiologic assay (MBA) 
(Lactobacillus rhamnosus 27773; ATCC) by using the microtiter plate adaptation of O’Broin 
et al. (23). The intra- and inter assay CVs for the serum folate quality-control standards (24) 
were 4.7%, 5.8%, and 7.5% and 7.2%, 10.8%, and 10.6% for the high, medium, and low 
standards, respectively. The intra- and interassay CVs for the RBC folate-positive controls 
were 5.5%, 6.1%, and 5.1% and 8.0%, 9.1%, and 8.7% for the high, medium, and low 
standards, respectively.
Biochemical indicators
For the purposes of this survey, the prevalence of folate deficiency was assessed by using 
both the WHO–radioproteinbinding assay (RPBA) cutoffs of <10 nmol/L for serum folate 
and <340 nmol/L for RBC folate (25) and the assay-matched cutoffs for the MBA of ≤14 
nmol/L for serum folate and <624 nmol/L for RBC folate from Pfeiffer et al. (26). In 
addition, RBC folate insufficiency was defined based on the recent WHO guideline 
establishing a threshold for the optimal RBC folate concentration for NTD risk reductions 
(<906 nmol/L) (15). The folate insufficiency cutoff (906 nmol/L) was adjusted for 
differences between the Irish MBA and the MBA as reported previously, resulting in an 
assay-adjusted cutoff for folate insufficiency of <748 nmol/L (27). The cutoff for identifying 
vitamin B-12 deficiency was <148 pmol/L, and it was 148–221 pmol/L for marginal vitamin 
B-12 deficiency (28). Anemia was defined by using WHO standards for hemoglobin 
concentrations in nonpregnant women (<12 g/dL) (29). Hemoglobin concentrations were 
adjusted for altitude as recommended by the WHO (29). A 5% threshold criterion has been 
established, above which prevalence estimates for folate deficiency (serum and RBC folate) 
and insufficiency (RBC folate), vitamin B-12 deficiency, and anemia were indicative of a 
public health concern (30).
Statistical methods
Statistical analyses were performed with SAS 9.3 (SAS Institute) and SUDAAN 
(version11.0; Research Triangle Institute). Sample weights and sample design variables were 
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used to produce nationally and regionally representative estimates that account for the 
clustered design and adjustments for household nonresponse (21). Descriptive analyses 
included national frequencies, percentages, and 95% CIs for sociodemographic variables 
(area, ethnicity, age, education, family income, reported use of folic acid–containing 
supplements, and use of health services) and region. The crude prevalence estimates and 
95% CIs for folate deficiency (serum and RBC concentrations), RBC folate insufficiency, 
vitamin B-12 deficiency and marginal deficiency, and anemia were determined. 
Comparisons with the selected variables were done by using prevalence risk ratios (PRRs) 
for serum and RBC folate and vitamin B-12 deficiencies. Adjusted PRRs were calculated by 
using logistic regression models to estimate the probability of RBC folate insufficiency and 
vitamin B-12 status (deficiency and marginally deficient). Adjusted PRRs were estimated 
from the logistic regression models by using the PREDMARG statement in SUDAAN (31). 
The adjusted PRRs were estimated by using the logistic regression model to estimate the 
probability of deficiency status, taking into account the covariates and the survey design.
Geometric means were used because distributions of blood folate and vitamin B-12 
concentrations were skewed. Geometric means by sociodemographic and other 
characteristics by using least mean square error algorithms derived from linear regression 
models (Proc Regress SUDAAN) were calculated as well. The 95% CIs for geometric 
means were constructed with Wald’s method (32). The Taylor series approximation was 
used to obtain the SEs (33). Pairwise differences were tested for geometric means of 
biomarker concentrations within each sociodemographic characteristic by using t tests 
derived from linear regressions to adjust for the selected variables.
Selected percentiles were estimated for overall serum and RBC folate and vitamin B-12 
concentrations, as well as the percentiles stratified by selected sociodemographic 
characteristics. RBC folate concentrations were assessed while stratifying by vitamin B-12 
status (deficient, marginally deficient, and normal) and by selected sociodemographic 
characteristics. In addition, linear trends for RBC folate concentrations by vitamin B-12 
status (treated as an ordinal variable) were tested by using multiple linear regression and 
adjusted by sociodemographic characteristics and region with the Satterwaite adjusted F-
statistic (34). All reported P values were based on 2-sided tests.
Results
Response rates
A total of 1869 households were identified. All households were contacted to determine 
their eligibility to participate in the study. In the end, 1156 households (61.9%) had one 
eligible WCBA. Of these, 88.6% agreed to participate. This yielded a total of 937 WCBA.
Characteristics of the study population
Table 1 summarizes the characteristics of the sample population: 51.3% lived in rural areas, 
53.2% were identified as of Mestizo ethnicity, 37.7% were 15–24 y of age, 23.1% had <6 y 
of education, and 29.9% reported a monthly family income of ≤699 BLZ$. In addition, 
67.0% reported the use of public health services only, 43.6% reported intake of folic acid–
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containing supplements, and 32.6% resided in the Central region. The Belize sample 
population reflected the Belizean general population of WCBA at the time (Supplemental 
Table 1). However, our sample population was less educated than the overall female 
Belizean population. Also, the ethnic distribution varied by region: The Central region was 
predominantly Black (Creole/Garifuna) and Mestizo (47.0% and 43.4%, respectively), the 
North and West regions were predominately Mestizo (80.7% and 61.4%, respectively), and 
the South region was predominantly Mayan (49.0%).
Prevalence of deficiencies and geometric means for serum and RBC folate, vitamin B-12, 
and anemia
The national prevalence estimates for serum folate deficiency and RBC folate deficiency by 
using the WHO-recommended cutoffs for deficiency were 4.1% (95% CI: 2.7%, 6.3%) and 
6.8% (95% CI: 4.9%, 9.4%), respectively, and by using the cutoffs from Pfeiffer et al. (26) 
were 11.0% (95% CI: 8.6%, 14.0%) and 35.1% (95% CI: 31.3%, 39.2%), respectively 
(Table 2). In addition, the prevalence for RBC folate insufficiency was 48.9% (95% CI: 
44.8%, 53.1%). The prevalence estimates for vitamin B-12 deficiency and marginal 
deficiency were 17.2% (95% CI: 14.2%, 20.6%) and 33.2% (95% CI: 29.6%, 37.1%), 
respectively. The prevalence of anemia was 22.7% (95% CI: 19.5%, 26.2%). The adjusted 
geometric means were 28 nmol/L (~95% CI: 26, 29 nmol/L) for serum folate, 719 nmol/L 
(~95% CI: 689, 750 nmol/L) for RBC folate, 233 pmol/L (~95% CI: 223, 244 pmol/L) for 
plasma vitamin B-12, and 12.7 g/dL (~95% CI: 12.5, 12.8 g/dL) for hemoglobin (Table 2). 
The percentile distributions for serum folate, RBC folate, and vitamin B-12 are given in 
Supplemental Table 2.
RBC folate insufficiency and vitamin B-12 deficiency and marginal deficiency by area, 
ethnicity, age, education level, income, and region
The prevalence estimates and PRRs for RBC folate insufficiency ranged from 33.5% to 
68.7% (Table 3) among the different subgroups. There was little variation by population 
characteristic except for a significantly higher insufficiency among Mayan WCBA than 
other ethnic groups [PRR 1.9 (95% CI: 1.2, 3.0)]. Plasma vitamin B-12 deficiency and 
marginal deficiency showed variations across some population characteristics and regions 
(Table 4). For vitamin B-12 deficiency, the only adjusted PRRs reaching statistical 
significance were for WCBA of Mayan and Mestizo origin [3.3 (95% CI: 1.3, 8.5) and 2.4 
(95% CI: 1.1, 5.3), respectively], WCBA with 7–12 y of education [2.2 (95% CI: 1.05, 4.7)], 
and WCBA in the South region [0.5 (95% CI: 0.3, 0.9)]. For marginal vitamin B-12 
deficiency, the only adjusted PRRs reaching significance were for WCBA of Mayan and 
Mestizo origin [2.1 (95% CI: 1.3, 3.5) and 1.9 (95% CI: 1.2, 2.9)] and for WCBA in the 
South region, with a significantly lower prevalence [0.7 (95% CI: 0.5, 0.8)].
Distribution of geometric means of serum and RBC folate and plasma vitamin B-12 
concentrations by sociodemographic characteristics
Variations in adjusted geometric mean concentrations and percentile distributions for serum 
and RBC folate and plasma vitamin B-12 were noted across some population characteristics 
and regions. Geometric mean concentrations of RBC folate were significantly lower among 
WCBA who were of Mayan origin and young and were significantly lower among WCBA in 
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the South and West regions (Table 5). Geometric mean concentrations of plasma vitamin 
B-12 were significantly lower among WCBA who were of Mayan origin and in the North 
region and were significantly higher among WCBA who used private health services and 
who reported taking a folic acid–containing supplement. Geometric mean concentrations of 
serum folate were significantly lower among WCBA aged 25–34 y, among WCBA with <6 y 
of education, among WCBA with family incomes of 700–1399 BLZ$, and among WCBA 
residing in the Central, South, and West regions (Supplemental Table 3).
Distribution of geometric means of RBC folate concentrations stratified by vitamin B-12 
status and selected population and geographic characteristics
Because of the high prevalence of vitamin B-12 deficiency and marginal deficiency among 
this population, adjusted geometric means of RBC folate concentration of participants were 
stratified according to vitamin B-12 status (i.e., deficient, marginally deficient, normal) and 
other participant characteristics (Figure 1, Supplemental Table 4). Overall, the national-
adjusted geometric means of RBC folate concentration increased significantly (P-trend < 
0.001) from 610 nmol/L among WCBA who were vitamin B-12 deficient to 641 nmol/L 
among WCBA with marginal vitamin B-12 deficiency to 783 nmol/L among WCBA who 
had a normal vitamin B-12 status. The trend was similar within most sociodemographic 
subgroups, with RBC folate concentration increasing across the 3 categories of vitamin B-12 
status. However, a statistically significant trend was not observed among the Mayan, Creole/
Garifuna, and Other ethnicity categories; among those 15–24 y old; those with ≥12 y 
education; those with family incomes of ≥700 BLZ$; among those using public/private or 
other health services; and among those residing in the Central and South regions.
RBC folate concentrations for each vitamin B-12 status and sociodemographic subgroup 
also were compared with the folate-insufficiency threshold (Figure 1). Adjusted geometric 
means of RBC folate concentrations were above the threshold for insufficiency (thus within 
the optimal range) for WCBA with normal vitamin B-12 levels nationally, for most 
demographic groups, and in the North region. In contrast, although RBC folate 
concentrations of WCBA of Mayan origin, WCBA who were users of private and private/
public health services, and WCBA residing in the South and West regions increased with 
improved vitamin B-12 status, they remained below the threshold for folate sufficiency for 
almost all vitamin B-12 subgroups.
Discussion
To our knowledge, this is Belize’s first national and regional premandatory fortification 
baseline survey to present data on folate status, vitamin B-12 status, and anemia prevalence 
among nonpregnant WCBA. It is also the first population-based survey, to our knowledge, to 
examine the association of vitamin B-12 status with RBC folate concentrations among 
nonpregnant WCBA. The results indicate that despite voluntary fortification of wheat flour, 
the prevalence estimates for folate and vitamin B-12 deficiency are much higher than the 
WHO threshold for public health concern. In particular, the greater prevalence of both folate 
and vitamin B-12 deficiency may lead to a higher incidence of NTDs and other adverse birth 
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outcomes in this population. In addition, anemia remains a moderate public health concern 
(29).
Folate and vitamin B-12 concentrations
National serum and RBC folate and vitamin B-12 concentrations among nonpregnant 
WCBA in our study were similar to or slightly lower than those reported from the 
postfortification period in Guatemala (28 compared with 30 nmol/L, 719 compared with 725 
nmol/L, and 233 compared with 341 pmol/L, respectively) (35). Also, we observed lower 
RBC folate and/or plasma vitamin B-12 concentrations in urban areas, among WCBA of 
Mayan origin, and in the West and South regions. These results were consistent with 
published results from Guatemala, other Latin American countries, and the United States 
(35–40), where variability of blood folate and vitamin B-12 concentrations within the 
population, as well as across racial and ethnic groups and regions, was observed. These 
differences could be explained in part by cultural differences and/or differences in access to 
or availability of fortified wheat flour for vulnerable populations (35).
Prevalence of folate deficiency and insufficiency, vitamin B-12 deficiency and marginal 
deficiency, and anemia
Comparison of folate status based on serum and RBC folate concentrations requires the use 
of the same assay and cutoffs to compare results within and between countries, it should 
discriminate between at-risk groups and those not at risk, and it should be validated through 
clinical trials (i.e., controlled folate depletion studies in which changes in clinical indexes 
are closely aligned with requirement). In our study, 2 different sets of cutoffs, those 
published by the WHO (25) and the assay-matched cutoffs of Pfeiffer et al. (26), were used 
to determine folate status. The WHO cutoffs are based on cross-sectional data from 
NHANES 1988–1994 that associated rising plasma homocysteine as a metabolic indicator of 
insufficient serum and RBC folate concentrations measured by using a commercial RPBA. 
This commercial assay grossly underestimates blood folate concentrations in a variable 
manner depending on genotype for a very common folate polymorphism (5,10-
methylenetetrahydrofolate reductase C677T), and the product was discontinued a decade 
ago. In contrast to the WHO cutoffs, the Institute of Medicine (41) previously reported 
cutoffs from controlled folate-depletion feeding studies in which folate was measured by 
MBA and cutoffs were defined based on hematological changes indicative of deficient 
erythropoiesis with the final stage being megaloblastic anemia. In our study, a substantially 
higher prevalence of folate deficiency based on serum (6.9% absolute difference) and RBC 
folate (28.9% absolute difference) concentrations was observed by using the assay-matched 
cutoffs from Pfeiffer et al. (26) compared with the WHO cutoffs (25). Thus, the prevalence 
of folate deficiency in Belize appears to be substantially higher than what the WHO cutoffs 
would suggest. This underscores the inappropriateness of using cutoffs based on the 
commercial RPBA to define folate status in studies in which blood folate was measured by 
using an MBA.
To compare like to like, our study compared results that used the WHO recommended 
cutoffs (25) to the results of other studies that used the same cutoffs. Belize, a country with a 
voluntary fortification program, had higher prevalence of serum folate deficiency (4.1%) 
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than several countries that have mandatory fortification, including the Dominican Republic 
(3.1%) (38), Mexico (1.9%) (42), Nicaragua (2.3%) (37), and the United States (<1%) (39). 
Similarly, the prevalence of RBC folate deficiency was greater in Belize (6.8%) than in 
Nicaragua (1.1%) (37) and the United States (<1%) (39). The amount of folic acid 
fortification in the aforementioned countries with mandatory fortification programs ranges 
between 140 and 180 mg/kg, and most of these countries fortify wheat and corn flour at a 
minimum. Surprisingly, folate deficiency was higher in 2 countries than in Belize 
(Guatemala: 5.1% or 8.9%, based on serum or RBC folate concentrations, respectively, and 
the Dominican Republic: 7.0% based on RBC folate concentrations) (35, 38). Differences 
between countries could be explained by differences in country characteristics and 
differences in their populations’ access to fortified staples.
By using the WHO threshold (15) as an indicator of optimal folate status, prevalence of 
folate insufficiency was observed among 49% of WCBA in Belize, placing them at a higher 
risk of NTD-affected pregnancy. This is an important public health concern (30). The 
prevalence of RBC folate insufficiency was slightly higher than that reported by Guatemala 
(47.2%) (43) but was much higher than that reported by the United States (22.1%) (27). 
Thus, with Belize’s voluntary folic acid fortification program, there is a high prevalence of 
folate deficiency and insufficiency. Because of this, many women are at greater risk of 
having an NTD-affected pregnancy. Guatemala’s program, although mandatory, has also had 
difficulty in reducing folate insufficiency. In both countries, vulnerable populations, such as 
the Mayans or the poor, have inadequate access to fortified wheat flour, limited purchasing 
power, and/or do not consume wheat flour as their main food staple (44). Fortification of 
additional staples, such as corn flour or rice, may be needed to reach at-risk populations and 
reduce folate insufficiency and prevent folate-sensitive NTDs. In contrast, the US population 
is more homogenous in its dietary practices and access to fortified staples. Also, the US 
population consumes multiple fortified staples, including breakfast cereals, which likely 
explains its lower prevalence of folate insufficiency (45).
Our study also found that the prevalence of vitamin B-12 deficiency and marginally deficient 
status (17.2%, and 33.2%, respectively) were of public health concern, although similar to 
those reported in Guatemala and other Latin American countries (35, 36, 40). Furthermore, 
vitamin B-12 concentrations in our study were lower than those reported from Guatemala 
(233 compared with 341 pmol/L). These differences are likely to be explained by a lower 
intake of meat products (40), suggesting that other sources of vitamin B-12, such as fortified 
food, may be necessary to address vitamin B-12 deficiency.
Anemia is also a public health concern in Belize with a prevalence of 22.7% among WCBA. 
The prevalence of anemia in Belize was higher than that reported in the United States (12%) 
(46), Guatemala (21.4%) (47), El Salvador (12%) (48), Costa Rica (10.2%) (48), and 
Nicaragua (11.2%) (48) and lower than that reported in the Dominican Republic (34%) (38) 
and Mexico (29.4%) (42). Of note, an elevated prevalence of anemia has persisted in these 
regions for many years despite efforts to increase iron intake (49).
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RBC folate concentrations stratified by vitamin B-12 status
In this study, WCBA characterized as vitamin B-12 deficient or marginally deficient did not 
have optimal RBC folate concentrations for reducing the risk of NTD-affected pregnancies. 
This finding was consistent across most sociodemographic subgroups (Figure 1) and is 
consistent with what is known about the interaction between vitamin B-12 and folate in the 
one-carbon metabolism pathway. Vitamin B-12 deficiency interferes with the one-carbon 
cycle by reducing the conversion of 5-methyl tetrahydrofolate to tetrahydrofolate and 
trapping folate in a metabolically less active form. As a result, DNA synthesis is reduced, 
thereby limiting the number of cells that can divide. Molloy et al. (5) reported that pregnant 
women with low vitamin B-12 concentrations [<250 ng/L (<184.5 pmol/L)] also had lower 
RBC folate concentrations and had a 2.5-times higher risk of giving birth to a child with an 
NTD.
Strengths and limitations
Our study has several major strengths. To our knowledge, it is the first study in Belize to 
assess micronutrient status at the national and regional levels among WCBA. This is 
especially important as Belize will be implementing mandatory fortification in the near 
future, and these results will provide a baseline against which future (postmandatory 
fortification) survey results can be compared. This study was designed and implemented by 
using a valid and reliable population-based sampling design and strict field and laboratory 
methodologies with the intent of reducing biases in the selection of households and 
individuals and to ensure proper handling of biological samples. Moreover, folate analysis 
was performed by using the MBA, which is considered the gold standard for determining 
circulating folate concentrations, particularly RBC folate because it measures all forms of 
folate exhibiting biological activity (50), thereby reducing biases because of the effect of the 
5,10-methylenetetrahydrofolate reductase gene polymorphism (15).
The study also has limitations, such as the lack of additional biomarkers of vitamin B-12 
(e.g., methylmalonic acid or holotranscobalamin) for improved status assessment, and the 
lack of data regarding dietary intake, an important component of nutrient status assessment. 
Somewhat surprisingly, self-reported use of folic acid–containing supplements was not 
correlated with measurements of blood folate. This suggests the limited reliability of using a 
self-reported measurement of supplement use without confirmatory evidence. In addition, 
the study included a relatively smaller sample size than required for some regions, which 
limited the precision for the estimation of biomarkers, resulting in wider CIs (the Central 
and, to a lesser degree, the North regions).
Conclusions
In Belize, the prevalence of folate and vitamin B-12 deficiencies continues to be a public 
health concern for WCBA. Folate deficiency and insufficiency were more prevalent among 
the Mayan population and women who were residing in the South region. Vitamin B-12 
deficiency was also widespread among WCBA. This study illustrates that when the assay 
type is matched with the appropriate assay cutoff, the prevalence of folate deficiency or 
insufficiency is higher than what would be reported by using mismatched cutoffs. In 
addition, this study provides evidence of the potential co-occurrence of low vitamin B-12 
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status and folate status, thus underlining the importance of providing adequate amounts of 
vitamin B-12 and folic acid to support NTD risk reduction. To assist in accomplishing this, 
Belize may benefit from mandatory micronutrient fortification programs that include the 
addition of folic acid and vitamin B-12 to staple foods such as rice and corn in addition to 
wheat flour to achieve sufficient intake of these nutrients among the population at risk. 
Finally, this study provides baseline information that will be useful for monitoring the 
effectiveness of future folic acid and vitamin B-12 fortification intervention programs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Adjusted geometric means and 95% CIs of RBC folate concentrations by vitamin B-12 
status and sociodemographic characteristics and region in women of childbearing age in 
Belize. The RBC folate optimal threshold is shown with a horizontal line. $BZ, Belize 
dollars.
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TABLE 1
Demographic and other characteristics of nonpregnant women of childbearing age, Belize 2011
Characteristic Unweighted n (N = 937) Weighted % (95% CI)
Area
 Rural 559 51.3 (43.8, 58.6)
 Urban 378 48.7 (41.4, 56.2)
Ethnicity
 Mayan 139 12.3 (9.3, 16.1)
 Mestizo 468 53.2 (47.7, 58.6)
 Black (Creole/Garifuna) 258 26.3 (21.8, 31.3)
 Other 72 8.2 (5.7, 11.7)
Age, y
 15–24 294 37.7 (33.7, 41.9)
 25–34 343 29.8 (26.5, 33.1)
 35–49 300 32.5 (28.7, 36.5)
Education, y
 <6 233 23.1 (19.6, 27.1)
 6–11 354 37.9 (33.4, 42.7)
 12 223 25.8 (22.0, 30.0)
 >12 127 13.2 (10.2, 16.8)
Monthly family income (BLZ$)1
 Don’t know 207 23.2 (19.5, 27.3)
 ≤699 290 29.9 (25.9, 34.1)
 700–1399 248 26.5 (22.9, 30.4)
 >1399 191 20.4 (17.1, 24.2)
Health services use
 Private 125 13.2 (10.8, 16.0)
 Private/public 100 10.3 (7.9, 13.4)
 Public 635 67.0 (62.3, 71.4)
 Other 77 9.4 (6.9, 12.9)
Use of folic acid–containing supplements in the last year
 No 538 56.4 (52.0, 50.7)
 Yes 399 43.6 (39.2, 48.0)
Region
 Central 223 32.6 (28.7, 36.7)
 North 208 26.3 (23.3, 29.6)
 South 243 17.7 (15.4, 20.3)
 West 263 23.4 (20.8, 26.1)
1
1 US$ = 2 BLZ$.
One missing value.
BLZ$, Belize dollar.
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TABLE 2
Geometric mean concentrations of folate, vitamin B-12, and anemia and prevalence of deficiency among 
nonpregnant women of childbearing age, Belize 2011
Indicator Unweighted n Geometric mean (95% CI) Prevalence (95% CI)
Serum folate 937 28 (26, 30)
 Deficiency (<10 nmol/L)1 46 8 (8, 9) 4.1 (2.7, 6.3)
 Deficiency (<14 nmol/L)2 117 10 (10, 11) 11.0 (8.6, 14.0)
RBC folate 937 719 (689, 750)
 Deficiency (<340 nmol/L)1 61 265 (252, 278) 6.8 (4.9, 9.4)
 Deficiency (<624 nmol/L)2 320 441 (422, 461) 35.1 (31.3, 39.2)
 Insufficiency (<906 nmol/L)3 6324 573 (552, 594) 68.5 (64.6, 72.2)
 Insufficiency (<748 nmol/L)2 4614 503 (483, 523) 48.9 (44.8, 53.1)
Plasma vitamin B-12 9305 233 (223, 244)
 Deficient (<148 pmol/L)6 160 121 (117, 125) 17.2 (14.2, 20.6)
 Marginally deficient (148–221 pmol/L)6 294 185 (183, 187) 33.2 (29.6, 37.1)
Hemoglobin 9315 12.7 (12.5, 12.8)
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TABLE 3
Prevalence and aPRRs of RBC folate insufficiency in nonpregnant women of childbearing age, Belize 20111
Characteristic
RBC folate insufficiency (<748 nmol/L)
Unweighted n Prevalence (95% CI) aPRR (95% CI)2
National 937 48.9 (44.8, 53.1)
Area
 Rural 559 49.1 (43.9, 56.1) 0.9 (0.8, 1.1)
 Urban 378 50.6 (44.5, 56.7) Referent
Ethnicity
 Mayan 139 70.5 (60.1, 79.2) 2.4 (1.4, 3.4)3
 Mestizo 468 46.2 (40.2, 52.3) 1.4 (0.9, 2.2)
 Black (Creole/Garifuna) 258 54.3 (46.3, 62.1) 1.6 (1.0, 2.5)
 Other 72 33.5 (21.0, 48.8) Referent
Age, y
 15–24 294 55.5 (48.2, 62.6) 1.2 (1.0, 1.4)
 25–34 343 48.7 (42.0, 55.3) 1.0 (0.9, 1.3)
 35–49 300 45.7 (38.6, 52.9) Referent
Education, y
 <6 233 47.4 (39.4, 55.6) 1.0 (0.7, 1.3)
 6–11 354 53.7 (46.7, 60.5) 1.1 (0.8, 1.5)
 12 223 50.8 (42.6, 58.9) 1.0 (0.8, 1.4)
 >12 127 44.4 (33.5, 55.9) Referent
Monthly family income, BLZ$
 Don’t know 207 48.5 (40.5, 56.6) 1.0 (0.8, 1.3)
 ≤699 290 51.9 (44.0, 59.6) 1.0 (0.8, 1.3)
 700–1399 248 53.4 (45.0, 61.0) 1.1 (0.8, 1.4)
 >1399 191 45.9 (36.8, 55.3) Referent
Health services use
 Private 125 42.9 (33.2, 53.5) 0.9 (0.7, 1.2)
 Private/public 100 59.5 (47.9, 70.2) 1.3 (1.1, 1.6)3
 Public 635 50.7 (45.6, 55.4) Referent
 Other 77 47.3 (32.3, 62.8) 0.9 (0.6, 1.3)
Use of folic acid–containing supplements in the last year
 No 538 53.0 (46.7, 59.2) 1.1 (0.9, 1.3)
 Yes 399 48.1 (46.3, 57.3) Referent
Region
 Central 208 50.3 (41.6, 59.0) 1.2 (0.9, 1.5)
 North 223 40.2 (32.3, 48.7) Referent
 South 243 60.4 (51.5, 68.7) 1.2 (0.9, 1.6)
 West 263 53.9 (46.8, 60.8) 1.2 (0.9, 1.6)
1
aPRR, adjusted prevalence risk ratio; BLZ$, Belize dollar.
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2
Adjusted by area, ethnicity, age, education, income, and region.
3
P < 0.0001.
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TABLE 5
National and regional adjusted geometric means of RBC folate and plasma vitamin B-12 concentrations by 
sociodemographic characteristics and regions for nonpregnant women of childbearing age, Belize 2011
Characteristic
RBC folate, nmol/L Vitamin B-12, pmol/L
n (unweighted) Geometric mean (95% CI)1 n (unweighted) Geometric mean (95% CI)
National 937 719 (689, 750) 930 233 (227, 243)
Area
 Rural 559 710 (663, 760) 557 247 (230, 265)
 Urban 378 706 (651, 765) 373 245 (227, 265)
Ethnicity
 Maya 139 579 (515, 651)2 139 214 (188, 243)3
 Mestizo 468 712 (661, 766)4 463 238 (223, 254)5
 Black (Creole/Garifuna) 258 755 (666, 788) 256 257 (234, 284)
 Other 72 841 (720, 982) 72 280 (249, 314)
Age, y
 15–24 294 671 (618, 729)6 291 249 (230, 271)
 25–34 343 709 (653, 769) 340 235 (219, 254)
 35–49 300 745 (690, 805) 299 253 (230, 279)
Education, y
 <6 233 736 (673, 804) 232 239 (217, 263)
 6–11 354 697 (652, 745) 351 257 (234, 278)7
 12 223 700 (643, 762) 220 232 (213, 254)
 >12 127 700 (616, 796) 127 257 (233, 284)
Monthly family income, BLZ$
 Don’t know 207 697 (632, 768) 202 234 (212, 259)
 ≤699 290 703 (643, 768) 290 246 (224, 271)
 700–1399 248 708 (652, 768) 246 249 (228, 271)
 >1399 191 724 (656, 800) 191 235 (212, 259)
Health services use
 Private 125 724 (652, 804) 122 278 (246, 315)8
 Private/public 100 663 (601, 732) 100 247 (225, 315)
 Public 635 728 (683, 776) 631 231 (220, 242)
 Other 77 717 (611, 842) 77 230 (201, 265)
Use of folic acid–containing supplements in the last year
 No 538 714 (662, 770) 536 233 (217, 250)9
 Yes 399 702 (654, 758) 394 260 (242, 279)
Region
 Central 208 803 (728, 886)10 204 254 (231, 281)11
 North 223 701 (628, 782) 221 215 (196, 236)
 South 243 682 (616, 755) 242 275 (248, 304)
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Characteristic
RBC folate, nmol/L Vitamin B-12, pmol/L
n (unweighted) Geometric mean (95% CI)1 n (unweighted) Geometric mean (95% CI)
 West 263 654 (601, 712) 263 244 (220, 270)
1
Adjusted for area, ethnicity, age, education, income, health services use, use of folic acid–containing supplements in the last year, and region. All 
pair-wise comparisons were made.
2
Maya vs. Mestizo, P < 0.002. Maya vs. Black (Creole/Garifuna), P < 0.001. Maya vs. Other, P < 0.001.
3
Maya vs. Black (Creole/Garifuna), P < 0.05. Maya vs. Other, P < 0.01.
4
Mestizo vs. Other, P < 0.05.
5
Mestizo vs. Other, P < 0.01.
6
15–19 vs. 35–49 y, P < 0.01.
7
6–11 vs. 12 y, P < 0.05.
8
Private vs. Public, P < 0.01.
9
No vs. Yes, P < 0.005.
10
Central vs. North, P < 0.05. Central vs. South, P < 0.05. Central vs. West, P < 0.001.
11
Central vs. North, P < 0.01. Central vs. South, P < 0.001. Central vs. West, P < 0.05.
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